Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, phase 2 trial
Titel:
Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, phase 2 trial
Auteur:
Larivière, Ynke Matuvanga, Trésor Zola Osang'ir, Bernard Isekah Milolo, Solange Meta, Rachel Kimbulu, Primo Robinson, Cynthia Katwere, Michael McLean, Chelsea Lemey, Gwen Matangila, Junior Maketa, Vivi Mitashi, Patrick Van geertruyden, Jean-Pierre Van Damme, Pierre Muhindo-Mavoko, Hypolite